After elucidating NLN as a potential therapeutic target and clarifying the molecular mechanisms by which inhibiting this target induces ferroptosis in lung cancer cells, we aim to further explore the clinical value of the NLN target, which could provide a scientific basis for its clinical translation. The gene discussed is NLN; the disease is lung cancer.